loading
전일 마감가:
$39.35
열려 있는:
$39.87
하루 거래량:
727.01K
Relative Volume:
0.69
시가총액:
$2.29B
수익:
$249.12M
순이익/손실:
$-90.19M
주가수익비율:
-24.25
EPS:
-1.7
순현금흐름:
$-88.21M
1주 성능:
-0.87%
1개월 성능:
-29.83%
6개월 성능:
-33.77%
1년 성능:
-48.64%
1일 변동 폭
Value
$39.27
$41.42
1주일 범위
Value
$38.67
$42.19
52주 변동 폭
Value
$37.12
$103.81

Procept Biorobotics Corp Stock (PRCT) Company Profile

Name
명칭
Procept Biorobotics Corp
Name
전화
(650) 232-9832
Name
주소
150 BAYTECH DRIVE, SAN JOSE
Name
직원
756
Name
트위터
Name
다음 수익 날짜
2024-10-28
Name
최신 SEC 제출 서류
Name
PRCT's Discussions on Twitter

PRCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
PRCT
Procept Biorobotics Corp
41.23 2.26B 249.12M -90.19M -88.21M -1.70
Medical Devices icon
ABT
Abbott Laboratories
132.59 226.73B 43.11B 13.94B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.17 152.69B 18.49B 2.50B 3.49B 1.68
Medical Devices icon
SYK
Stryker Corp
394.22 145.89B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
92.71 118.91B 33.54B 4.69B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
81.83 45.97B 5.69B 1.41B 577.90M 6.95

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-09 개시 Stephens Overweight
2025-07-07 개시 Oppenheimer Perform
2024-12-02 개시 Morgan Stanley Overweight
2024-11-14 개시 Jefferies Hold
2023-08-11 개시 Piper Sandler Overweight
2023-05-31 개시 William Blair Outperform
2022-10-31 개시 BTIG Research Neutral
2022-10-25 개시 Truist Buy
2022-09-02 개시 Wells Fargo Overweight
2022-07-15 개시 KeyBanc Capital Markets Overweight
2022-06-23 개시 B. Riley Securities Buy
2021-10-11 개시 BofA Securities Buy
2021-10-11 개시 Cowen Outperform
2021-10-11 개시 Goldman Neutral
2021-10-11 개시 Guggenheim Buy
2021-10-11 개시 SVB Leerink Outperform
모두보기

Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스

pulisher
Aug 20, 2025

PROCEPT BioRobotics Corporation Attempts Reversal From Key SupportJuly 2025 Update & Fast Entry and Exit Trade Plans - classian.co.kr

Aug 20, 2025
pulisher
Aug 16, 2025

PROCEPT BioRobotics Independent Director Acquires 2.4% More Stock - 富途牛牛

Aug 16, 2025
pulisher
Aug 16, 2025

Overvalued Healthcare Tech Stocks: How Predictive Models Can Anticipate Market Corrections—A Case Study of PROCEPT BioRobotics (PRCT) - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

Why PROCEPT BioRobotics (PRCT) Is Up 8.3% After Raising 2025 Revenue Guidance - simplywall.st

Aug 16, 2025
pulisher
Aug 15, 2025

PROCEPT BioRobotics Corporation Shows Risk Reward Favoring Upside2025 Year in Review & Accurate Entry and Exit Point Alerts - 선데이타임즈

Aug 15, 2025
pulisher
Aug 15, 2025

Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionAnalyst Upgrade & Entry and Exit Point Strategies - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 14, 2025

Director’s Bold Move: Major Investment in PROCEPT BioRobotics - TipRanks

Aug 14, 2025
pulisher
Aug 14, 2025

Procept BioRobotics: A High-Growth Buy with Strengthening Pricing Power and Global Expansion Momentum - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Procept BioRobotics: Boosting Average Selling Price, Initiates Buy Rating - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy (NASDAQ:PRCT) - Seeking Alpha

Aug 14, 2025
pulisher
Aug 14, 2025

PROCEPT BioRobotics 15min chart: RSI Oversold, KDJ Golden Cross detected. - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT) - MSN

Aug 14, 2025
pulisher
Aug 12, 2025

PROCEPT BioRobotics (PRCT) Guides Higher on Q2 Revenue Beat and Narrowing Losses – What Signals Ahead? - simplywall.st

Aug 12, 2025
pulisher
Aug 11, 2025

Procept BioRobotics Grows Fast Despite Wall Street Skepticism - Finimize

Aug 11, 2025
pulisher
Aug 10, 2025

PROCEPT BioRobotics Reports Strong Q2 2025 Growth - TipRanks

Aug 10, 2025
pulisher
Aug 10, 2025

Why PROCEPT BioRobotics Shares Are Tumbling - TipRanks

Aug 10, 2025
pulisher
Aug 09, 2025

Procept Biorobotics Reports Strong Q2 Growth Amid Challenges - TipRanks

Aug 09, 2025
pulisher
Aug 09, 2025

PROCEPT BioRobotics outlines $325.5M 2025 revenue target amid leadership transition and margin expansion - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S After Its 34% Share Price Crash - simplywall.st

Aug 09, 2025
pulisher
Aug 08, 2025

Procept Biorobotics Corp.’s Aquablation Therapy: A Promising Update for Prostate Cancer Treatment - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Edwards’ Longtime TAVR Leader is Named PROCEPT BioRobotics CEO - Medical Product Outsourcing

Aug 08, 2025
pulisher
Aug 08, 2025

A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $55 to $83 - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$65.75 Price Target - simplywall.st

Aug 08, 2025
pulisher
Aug 08, 2025

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Qiagen (QGEN) - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

PROCEPT BioRobotics 2025 Q2 Earnings Improved Losses Amid Revenue Surge - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

PROCEPT BioRobotics Posts Q2 2025 Earnings: Revenue Up 48%, Net Loss Narrows by 24% - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

PROCEPT BioRobotics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Buy Rating for PROCEPT BioRobotics: Growth Potential and Stability Amid Sales Beat and Improved Guidance - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Procept BioRobotics' Q2 Revenue Jumps 48%, Exceeds Estimates - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

PROCEPT BioRobotics Reports 48% YoY Revenue Growth in Q2 2025 - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Procept Biorobotics shares fall 13.46% intraday despite increased revenue guidance for 2025. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $85 to $85 - 富途牛牛

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Procept BioRobotics Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings call transcript: Procept BioRobotics Q2 2025 beats forecasts, stock dips - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

Truist Lowers Price Target on PROCEPT BioRobotics to $64 From $70, Keeps Buy Rating - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Wells Fargo lowers Procept BioRobotics stock price target on delayed system replacements - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Optimistic Outlook on PROCEPT BioRobotics Amidst Medtech Sector Challenges - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

PROCEPT BioRobotics (PRCT): Assessing the Path to Profitability Amid Leadership Transition and Global Expansion - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

PROCEPT BioRobotics Sets $325.5M 2025 Revenue Target Amid Leadership Change and Margin Expansion - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Transcript : PROCEPT BioRobotics Corporation, Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Procept (PRCT) Q2 Revenue Jumps 48% - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Procept (PRCT) Q2 Revenue Jumps 48% - The Motley Fool

Aug 06, 2025
pulisher
Aug 06, 2025

PROCEPT BioRobotics (PRCT) Earnings Transcript - Mitrade

Aug 06, 2025
pulisher
Aug 06, 2025

Procept Biorobotics shares fall 3.72% after-hours despite Q2 revenue up 48% and raised 2025 guidance. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Procept Biorobotics earnings beat by $0.06, revenue topped estimates - Investing.com South Africa

Aug 06, 2025
pulisher
Aug 06, 2025

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Zimmer Biomet (ZBH) Q2 Revenue Jumps 7% - AOL.com

Aug 06, 2025
pulisher
Aug 06, 2025

PROCEPT BioRobotics Q2 revenue up 48% YoY to $79.2mln. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results - TradingView

Aug 06, 2025

Procept Biorobotics Corp (PRCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Procept Biorobotics Corp 주식 (PRCT) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
MOLL FREDERIC H
Director
Aug 13 '25
Buy
39.26
20,000
785,138
863,159
Nouri Alaleh
EVP, CLO, CORP. SEC.
Aug 14 '25
Option Exercise
4.52
11,000
49,720
72,473
Desai Antal Rohit
Director
Jun 10 '25
Sale
63.91
25,000
1,597,711
64,363
Desai Antal Rohit
Director
Jun 11 '25
Sale
63.38
25,000
1,584,525
39,363
Desai Antal Rohit
Director
Jun 12 '25
Sale
61.49
25,000
1,537,256
14,363
$330.77
price up icon 0.89%
medical_devices STE
$251.87
price up icon 1.77%
medical_devices PHG
$28.34
price up icon 3.28%
$82.26
price up icon 2.03%
$75.22
price up icon 2.83%
medical_devices EW
$81.83
price up icon 0.83%
자본화:     |  볼륨(24시간):